An update on crop biotechnology in Burkina Faso

An update on crop biotechnology in Burkina Faso:
Forum international biotechnologie Burkina Faso

Spotlight

Proteomics International - Biosimilars, Biomarkers & Therapeutics

Founded 2001 Listed on ASX April 2015 - Proteomics International Laboratories Ltd (PILL, ASX: PIQ) Proteomics International is a medical technology company focused on proteomics – the industrial-scale study of the structure and function of proteins. Proteomics International has over 16 years of experience in providing specialist analytical services on a fee-for-service basis . The strength of the company’s research expertise in finding new diagnostic protein biomarkers has also resulted in a ground-breaking predictive test for diabetic kidney disease – PromarkerD.

OTHER VIDEOS

Image analysis software for true ultra high content data on the MACSima™ Imaging System

video | July 28, 2023

Qi Tissue Image Analysis Software for the MACSima™ Imaging Platform is the key to unlocking staggering analytical ability with ultra high content imaging data generated on the revolutionary new MACSima Imaging Platform....

Watch Now

Bioprinting Living Cells: The Next Frontier in Biotechnology Technology

video | July 30, 2023

Bioprinting with living human cells is transforming healthcare as we know it. From Slurpee-like substances to molding 3D tissues, explore the cutting-edge world of 3D bioprinting. Dr. Mark Skylar-Scott from Stanford University discusses the fascinating realm of 3D bioprinting, a groundbreaking approach that goes beyond traditional plastic printing....

Watch Now

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now

Spotlight

Proteomics International - Biosimilars, Biomarkers & Therapeutics

Founded 2001 Listed on ASX April 2015 - Proteomics International Laboratories Ltd (PILL, ASX: PIQ) Proteomics International is a medical technology company focused on proteomics – the industrial-scale study of the structure and function of proteins. Proteomics International has over 16 years of experience in providing specialist analytical services on a fee-for-service basis . The strength of the company’s research expertise in finding new diagnostic protein biomarkers has also resulted in a ground-breaking predictive test for diabetic kidney disease – PromarkerD.

Events